Effect of INIT on Cervical Proprioception in Patients With Forward Head Posture
Launched by RIPHAH INTERNATIONAL UNIVERSITY · Dec 12, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a treatment called Integrated Neuromuscular Inhibition Technique (INIT) to see how it affects neck awareness in people with a condition known as Forward Head Posture. This is when the head is positioned too far forward, which can lead to neck pain and other issues. The trial is taking place at Riphah International University in Islamabad and includes 42 participants aged between 18 and 40 who have been experiencing neck pain for over three months. To qualify, participants must have a specific angle of neck misalignment (less than 50 degrees) and certain tight muscles in their neck.
If you or someone you know is interested in participating, keep in mind that participants will be divided into two groups and will undergo assessments at different points during the study, including after initial sessions and at two and four weeks. The study aims to gather information on how well this treatment works and will use various tools to measure changes in neck movement and pain levels throughout the six-month period. However, those with a history of neck injuries, certain medical conditions, or cognitive issues may not be eligible to join the trial.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Both Male and Female patients
- • CVA less than 50 degree
- • Age 18-40 years
- • Neck pain for more than 3 months
- • NPRS \> 3
- • Decreased Cervical ROMs
- • Active trigger points in following muscles (Upper Trapezius, Sternocleidomastoid, Levator Scapulae)
- Exclusion Criteria:
- • History of cervical or facial trauma or surgery.
- • Congenital anomalies of spine such as scoliosis.
- • Systemic arthritis.
- • Any disorder of Central Nervous System.
- • Patients with cognitive deficit
About Riphah International University
Riphah International University is a leading educational institution based in Pakistan, dedicated to advancing healthcare and medical research through innovative clinical trials. With a commitment to excellence in research and education, Riphah emphasizes ethical standards and scientific integrity in its clinical studies. The university collaborates with various stakeholders, including healthcare professionals and industry partners, to enhance patient outcomes and contribute to the global body of medical knowledge. Through its robust research programs, Riphah International University aims to foster a culture of inquiry and improve healthcare delivery both locally and internationally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Islamabad, Federal, Pakistan
Patients applied
Trial Officials
Lal Gul Khan, MScPT
Principal Investigator
Riphah International University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported